Publications

Found 147 results
Type [ Year(Asc)]
2011
CA Gersbach. "Engineered bioactive molecules." 5 (2011): 131-145.
CA Gersbach. "Engineered Proteins for Controlling Gene Expression." (2011): 159-176.
T Gaj, AC Mercer, CA Gersbach, RM Gordley, and CF Barbas. "Structure-guided reprogramming of serine recombinase DNA sequence specificity." Proceedings of the National Academy of Sciences of the United States of America 108, no. 2 (2011): 498-503.
T Gaj, AC Mercer, CA Gersbach, RM Gordley, and CF Barbas. "Structure-guided reprogramming of serine recombinase DNA sequence specificity." Proceedings of the National Academy of Sciences of the United States of America 108, no. 2 (2011): 510-515.
CA Gersbach, T Gaj, RM Gordley, AC Mercer, and CF Barbas. "Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase." Nucleic Acids Research 39, no. 17 (2011): 7868-7878.
2010
CA Gersbach, T Gaj, RM Gordley, and CF Barbas. "Directed evolution of recombinase specificity by split gene reassembly." Nucleic Acids Research 38, no. 12 (2010): 4198-4206.
2009
RM Gordley, CA Gersbach, and CF Barbas. "Synthesis of programmable integrases." Proceedings of the National Academy of Sciences of the United States of America 106, no. 13 (2009): 5053-5058.
2007
CA Gersbach,, JM Le Doux, and AJ García. "Biomaterial-mediated retroviral gene transfer using self-assembled monolayers." Biomaterials 28, no. 34 (2007): 5121-5127.
CA Gersbach, JE Phillips, and AJ García. "Genetic engineering for skeletal regenerative medicine." Annual Review of Biomedical Engineering 9 (2007): 87-119.
S Pregizer, A Barski, CA Gersbach, AJ García, and B Frenkel. "Identification of novel Runx2 targets in osteoblasts: cell type-specific BMP-dependent regulation of Tram2." Journal of Cellular Biochemistry 102, no. 6 (2007): 1458-1471.
CA Gersbach, RE Guldberg, and AJ García. "In vitro and in vivo osteoblastic differentiation of BMP-2- and Runx2-engineered skeletal myoblasts." Journal of Cellular Biochemistry 100, no. 5 (2007): 1324-1336.
JE Phillips, CA Gersbach, and AJ García. "Virus-based gene therapy strategies for bone regeneration." Biomaterials 28, no. 2 (2007): 211-229.
2006
JE Phillips, CA Gersbach, AM Wojtowicz, and AJ García. "Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation." Journal of Cell Science 119, no. Pt 3 (2006): 581-591.
CA Gersbach, JM Le Doux, RE Guldberg, and AJ García. "Inducible regulation of Runx2-stimulated osteogenesis." Gene Therapy 13, no. 11 (2006): 873-882.
2005
MA Lan, CA Gersbach, KE Michael, BG Keselowsky, and AJ García. "Myoblast proliferation and differentiation on fibronectin-coated self assembled monolayers presenting different surface chemistries." Biomaterials 26, no. 22 (2005): 4523-4531.
CA Gersbach, JE Phillips, RE Guldberg, and AJ García. "Runx2-genetically engineered cells for bone tissue engineering." Proceedings of the 2005 Summer Bioengineering Conference 2005 (2005): 603-604.
J Drevs, U Zirrgiebel, CIM Schmidt-Gersbach, K Mross, M Medinger, L Lee, J Pinheiro, J Wood, AL Thomas, C Unger et al. "Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials." Annals of Oncology 16, no. 4 (2005): 558-565.
2004
CA Gersbach, BA Byers, GK Pavlath, and AJ García. "Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype." Experimental Cell Research 300, no. 2 (2004): 406-417.
CA Gersbach. "Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype." Exp. Cell Res. 300 (2004): 406-417.
CA Gersbach, BA Byers, GK Pavlath, RE Guldberg, and AJ García. "Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro." Biotechnology and Bioengineering 88, no. 3 (2004): 369-378.
CA Gersbach, BA Byers, RE Guldberg, GK Pavlath, and AJ García. "Runx2-stimulated transdifferentiation of primary skeletal myoblasts into an osteoblastic mineralizing phenotype for bone tissue engineering." Transactions 7th World Biomaterials Congress (2004).
2003
AJ García, RE Guldberg, BA Byers, CA Gersbach, and JE Phillips. "Addressing cell-sourcing limitations with gene therapy." Ieee Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society 22, no. 5 (2003): 65-70.

Pages